Chk1: A Double Agent in Cell Cycle Checkpoints  by Yu, Hongtao
Developmental Cell
PreviewsChk1: A Double Agent in Cell Cycle Checkpoints
Hongtao Yu1,*
1Department of Pharmacology, University of Texas Southwestern Medical Center, 6001 Forest Park Road, Dallas, TX 75390, USA
*Correspondence: hongtao.yu@utsouthwestern.edu
DOI 10.1016/j.devcel.2007.01.005
Two cell cycle surveillance systems––the DNA damage checkpoint and the spindle checkpoint––
guard against genomic instability. The protein kinase Chk1 is a well-established signal transducer
in the DNA damage checkpoint. In this issue of Developmental Cell, Zachos et al. (2007) present
evidence to indicate that Chk1 also plays a critical role in the spindle checkpoint, suggesting an
interplay between the DNA damage and spindle checkpoints.The cell division cycle is driven by fluc-
tuating activities of cyclin-dependent
kinases (Cdk) and consists of a series
of tightly coordinated and interdepen-
dent processes, including DNA repli-
cation in S phase and sister-chromatid
separation inmitosis. Cell cycle check-
points are surveillance mechanisms
that halt the cell cycle at appropriate
stages in response either to exoge-
nous damages to DNA or the mitotic
spindle or to the incompleteness of a
given cell cycle process, such as DNA
replication or chromosome alignment
(Figure 1). Upon DNA damage caused
by ionizing radiation (IR), ultraviolet
light (UV), chemicals, or replication
stress, the DNA damage checkpoint
blocks the cell cycle at multiple junc-
tures, including the G1-S and G2-M
transitions (Kastan and Bartek, 2004).
This affords cells windows of opportu-
nities to repair their DNA or commit
apoptosis, thus preventing the pas-
sage of genetic alterations to the next
generation. The spindle checkpoint
senses the existence of sister chroma-
tids that have not achieved proper
attachment to the mitotic spindle and
delays the onset of anaphase, thus
ensuring the fidelity of chromosome
segregation (Bharadwaj and Yu, 2004).
Malfunctions of these cell cycle check-
points result in genomic instability and
promote tumorigenesis.
In the DNA damage checkpoint, two
apical kinases, ATM (ataxia telangiec-
tasia mutated) and ATR (ATM and
Rad3 related), are activated following
recruitment to nuclei foci that are be-
lieved to be sites of DNA damage and
repair (Kastan and Bartek, 2004). ATR
and ATM then phosphorylate and acti-
vate two signal-transducing kinases,Chk1 and Chk2, which in turn phos-
phorylate key downstream effectors,
including p53 and the Cdc25 family
of phosphatases (Figure 1). Chk1/
2-mediated phosphorylation of p53
causes its stabilization and accumula-
tion, leading to the elevated transcrip-
tion of p21, a Cdk inhibitor. Phosphor-
ylation of Cdc25 proteins leads to their
degradation, sequestration, and/or in-
hibition, preventing them from remov-
ing inhibitory phosphorylation on Cdk1
or Cdk2. Collectively, these mecha-
nisms block the activation of Cdk1 or
Cdk2 and critical cell cycle transitions.
In the spindle checkpoint, the Au-
rora B-INCENP kinase complex lies
at the top of a cascade that recruits
other spindle checkpoint proteins to
kinetochores that are not attached by
microtubules and/or not under ten-
sion, including kinases such as Mps1,
Bub1, and BubR1 (Figure 1) (Vigneron
et al., 2004). The kinetochore recruit-
ment of the checkpoint proteins is
believed to facilitate the binding of
BubR1 and Mad2 to Cdc20 (Bharad-
waj and Yu, 2004) and to activate the
kinase activity of Bub1 toward Cdc20
(Tang et al., 2004). Mad2/BubR1 bind-
ing and Bub1-mediated phosphor-
ylation of Cdc20 inhibit the ubiquitin
ligase activity of the anaphase-pro-
moting complex or cyclosome (APC/C)
(Tang et al., 2001, 2004), resulting in
the stabilization of securin and cyclin
B1. This delays the activation of sepa-
rase, cleavage of cohesin, and the
onset of anaphase.
Both the DNA damage and spindle
checkpoints are intracellular signal
transduction pathways and share
several common operating principles.
Most notably, both checkpoints con-Developmental Cell 12tain protein kinase cascades that
receive and propagate checkpoint sig-
nals, although relatively less is known
about the kinase cascade in the spin-
dle checkpoint. The findings of Zachos
et al. (2007) represent an important
step forward in this area and indicate
that the two major cell cycle check-
points not only share mechanistic par-
allels in their operations, but they also
share certain common components.
Zachos et al. started their investi-
gation by examining the possible mi-
totic functions of Chk1, a key compo-
nent of the DNA damage checkpoint
(Zachos et al., 2007). They showed
that genetic ablation of Chk1 (Chk1/)
in chicken DT40 cells or depletion of
Chk1 from human BE colon can-
cer cells by RNA interference (RNAi)
causes chromosome missegregation,
resulting in abnormal karyotypes. To
further probe the potential function of
Chk1 in the spindle checkpoint, they
treated Chk1/ DT40 cells or Chk1
RNAi human cells with two spindle
poisons––Taxol, which stabilizes mi-
crotubules and reduces tension across
paired kinetochores, or nocodazole,
which depolymerizes microtubules
and renders all kinetochores unat-
tached. While the Chk1-deficient cells
undergo mitotic arrest when treated
with nocodazole, these cells fail to
arrest in mitosis in the presence of
Taxol. Importantly, ectopic expression
of the wild-type Chk1, but not its
kinase-inactive mutant, in Chk1/
DT40 cells restores mitotic arrest in
the presence of Taxol, indicating that
the kinase activity of Chk1 is required
for Taxol-triggered mitotic arrest.
Consistent with a role of Chk1 in the
spindle checkpoint, the Chk1-GFP, February 2007 ª2007 Elsevier Inc. 167
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cruited to mitotic kinetochores? What
is the kinase that mediates phosphory-
lation of Chk1 in mitosis? What are the
functions of these mitotic phosphory-
lation events on Chk1, as they do not
appear to enhance its kinase activity?
Are ATR and to a lesser extent ATM
that act upstream of Chk1 in the DNA
damage checkpoint also involved in
the spindle checkpoint? Recent stud-
ies have shown that the DNA damage
response is chronically activated in
cancer cells (Bartkova et al., 2005),
possibly including those used in the
study by Zachos et al. (2007). It will
be interesting to determine whether it
is this chronic activation of the DNA
damage response that sustains the ki-
nase activity of Chk1 and contributes
to spindle checkpoint signaling and
whether Chk1 is dispensable for the
spindle checkpoint in normal untrans-
formed cells. Future studies aimed at
answering these questions may reveal
a closer than expected kinship be-
tween the DNA damage and spindle
checkpoints.
Figure 1. Simplified Schemes of the DNA Damage and Spindle Checkpoints that
Highlight the Functions of Chk1
In the DNA damage checkpoint, Chk1 acts downstream of ATR and ATM to phosphorylate p53
and Cdc25A/C among other effectors, thus blocking G1-S and G2-M transitions. In the spin-
dle checkpoint, Chk1 contributes to the activation of Aurora B in response to kinetochores that
are not under tension. Aurora B then signals through the Bub and Mad proteins to inhibit
APC/CCdc20 and delays the metaphase-anaphase transition.fusion protein localizes to kinetochores
in DT40 cells in prometaphase. Fur-
thermore, the kinetochore localization
of BubR1 is diminished in Chk1-defi-
cient chicken DT40 and human BE
cells during unperturbed mitosis and
in the presence of Taxol, whereas
BubR1 and Mad2 localize normally to
kinetochores in nocodazole-treated
Chk1-deficient cells. These observa-
tions suggested that Chk1 is specifi-
cally required for the tension-sensing
branch of the spindle checkpoint.
As a similar function has been as-
cribed to Aurora B (Ditchfield et al.,
2003; Hauf et al., 2003), Zachos et al.
next examined whether Chk1 and
Aurora B lie in the same pathway
(Zachos et al., 2007). Though Chk1 is
phosphorylated at sites that are dis-
tinct from the conventional ATM/ATR
sites in Taxol-treated mitotic cells,
the kinase activity of Chk1 does not
appear to increase in mitosis. Inhibi-
tion of Aurora B kinase activity in
DT40 cells with a chemical inhibitor
(VX-680) does not affect the kineto-
chore localization of Chk1-GFP or mi-
totic phosphorylation of Chk1. In con-168 Developmental Cell 12, February 200trast, despite its proper kinetochore
localization, Aurora B is not fully acti-
vated in Chk1-deficient cells in the
presence of Taxol, as judged by the
reduced phosphorylation of CENP-A
and BubR1 in cells and by the reduced
kinase activity of immunoprecipitated
Aurora B toward histone H3 in vitro.
Chk1 phosphorylates and activates
Aurora B in vitro independently of
INCENP. Therefore, Chk1 appears to
lie upstream of Aurora B in the tension-
sensing branch of the spindle check-
point. On the other hand, inhibition of
Aurora B by VX-680 further exacer-
bates the checkpoint defects of
Chk1-deficient cells, indicating that
Aurora B can be activated in Chk1-
independent manners, presumably
through INCENP (Vader et al., 2006).
While this elegant work by Zachos
et al. clearly establishes a role of
Chk1––a well-known DNA damage
checkpoint kinase––in the spindle
checkpoint (Zachos et al., 2007), it
also raisesmany interesting questions.
For example, how does phosphoryla-
tion of Aurora B by Chk1 activate the
kinase activity of Aurora B? Does this7 ª2007 Elsevier Inc.REFERENCES
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